Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Sees Significant Growth in Short Interest

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) was the recipient of a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling 15,707 shares, a growth of 80.4% from the December 31st total of 8,707 shares. Based on an average daily volume of 12,731 shares, the days-to-cover ratio is presently 1.2 days. Based on an average daily volume of 12,731 shares, the days-to-cover ratio is presently 1.2 days.

Coeptis Therapeutics Stock Up 1.6%

COEPW traded up $0.00 during midday trading on Friday, hitting $0.01. The company’s stock had a trading volume of 1,871 shares, compared to its average volume of 18,442. Coeptis Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.05. The firm has a 50-day moving average price of $0.01 and a two-hundred day moving average price of $0.02.

Coeptis Therapeutics Company Profile

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.